Argentarii LLC Makes New $2.63 Million Investment in Welltower Inc. (NYSE:WELL)

Argentarii LLC bought a new position in shares of Welltower Inc. (NYSE:WELL) in the 4th quarter, Holdings Channel reports. The institutional investor bought 20,838 shares of the real estate investment trust’s stock, valued at approximately $2,626,000. Welltower accounts for about 1.3% of Argentarii LLC’s holdings, making the stock its 15th largest position.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in WELL. Roxbury Financial LLC bought a new position in shares of Welltower in the 4th quarter valued at $26,000. Laurel Wealth Advisors LLC bought a new position in shares of Welltower in the 4th quarter valued at $25,000. Sierra Ocean LLC bought a new position in shares of Welltower in the 4th quarter valued at $28,000. Versant Capital Management Inc lifted its stake in shares of Welltower by 165.5% in the 4th quarter. Versant Capital Management Inc now owns 300 shares of the real estate investment trust’s stock valued at $38,000 after acquiring an additional 187 shares during the last quarter. Finally, Ashton Thomas Securities LLC bought a new position in shares of Welltower in the 3rd quarter valued at $50,000. 94.80% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on WELL shares. Scotiabank increased their price target on Welltower from $165.00 to $166.00 and gave the company a “sector outperform” rating in a research note on Thursday. Evercore ISI increased their price target on Welltower from $144.00 to $145.00 and gave the company an “in-line” rating in a research note on Tuesday, March 4th. Mizuho increased their price target on Welltower from $136.00 to $141.00 and gave the company an “outperform” rating in a research note on Thursday, December 5th. Bank of America increased their price target on Welltower from $221.00 to $242.00 and gave the company a “buy” rating in a research note on Tuesday, February 18th. Finally, StockNews.com downgraded Welltower from a “hold” rating to a “sell” rating in a report on Thursday, February 13th. One research analyst has rated the stock with a sell rating, two have given a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $148.42.

Welltower Stock Performance

Shares of Welltower stock opened at $147.22 on Friday. The company has a current ratio of 4.22, a quick ratio of 4.22 and a debt-to-equity ratio of 0.48. The business has a 50-day moving average price of $138.99 and a two-hundred day moving average price of $132.75. Welltower Inc. has a 1-year low of $87.87 and a 1-year high of $158.55. The company has a market cap of $94.41 billion, a P/E ratio of 94.37, a PEG ratio of 2.87 and a beta of 1.20.

Welltower (NYSE:WELL) last issued its earnings results on Tuesday, February 11th. The real estate investment trust reported $1.13 EPS for the quarter, beating the consensus estimate of $0.40 by $0.73. Welltower had a return on equity of 3.15% and a net margin of 11.91%. As a group, analysts anticipate that Welltower Inc. will post 4.88 EPS for the current year.

Welltower Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 6th. Investors of record on Tuesday, February 25th were given a $0.67 dividend. The ex-dividend date of this dividend was Tuesday, February 25th. This represents a $2.68 annualized dividend and a yield of 1.82%. Welltower’s payout ratio is 171.79%.

Welltower Company Profile

Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.